Literature DB >> 28291882

Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year.

Rebecca L Winslow1, Iain D Milligan1, Merryn Voysey2, Kerstin Luhn3, Georgi Shukarev3, Macaya Douoguih3, Matthew D Snape1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28291882     DOI: 10.1001/jama.2016.20644

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  28 in total

1.  Rigorous Clinical Trial Design in Public Health Emergencies Is Essential.

Authors:  Susan S Ellenberg; Gerald T Keusch; Abdel G Babiker; Kathryn M Edwards; Roger J Lewis; Jens D Lundgren; Charles D Wells; Fred Wabwire-Mangen; Keith P W J McAdam
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

Review 2.  Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.

Authors:  John J Suschak; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

Review 3.  Zika virus vaccines.

Authors:  Peter Abbink; Kathryn E Stephenson; Dan H Barouch
Journal:  Nat Rev Microbiol       Date:  2018-10       Impact factor: 60.633

4.  NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans.

Authors:  Helen R Wagstaffe; Omu Anzala; Hannah Kibuuka; Zacchaeus Anywaine; Sodiomon B Sirima; Rodolphe Thiébaut; Laura Richert; Yves Levy; Christine Lacabaratz; Viki Bockstal; Kerstin Luhn; Macaya Douoguih; Martin R Goodier
Journal:  Vaccines (Basel)       Date:  2022-05-31

Review 5.  Considerations for use of Ebola vaccine during an emergency response.

Authors:  Jenny A Walldorf; Emily A Cloessner; Terri B Hyde; Adam MacNeil
Journal:  Vaccine       Date:  2017-09-07       Impact factor: 3.641

6.  Prevention of Ebola virus disease through vaccination: where we are in 2018.

Authors:  Yves Lévy; Clifford Lane; Peter Piot; Abdul Habib Beavogui; Mark Kieh; Bailah Leigh; Seydou Doumbia; Eric D'Ortenzio; Claire Lévy-Marchal; Jerome Pierson; Deborah Watson-Jones; Vinh-Kim Nguyen; Heidi Larson; Julia Lysander; Christine Lacabaratz; Rodolphe Thiebaut; Augustin Augier; David Ishola; Stephen Kennedy; Geneviève Chêne; Brian Greenwood; James Neaton; Yazdan Yazdanpanah
Journal:  Lancet       Date:  2018-08-10       Impact factor: 79.321

7.  A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Authors:  Benoit Callendret; Jort Vellinga; Kerstin Wunderlich; Ariane Rodriguez; Robin Steigerwald; Ulrike Dirmeier; Cedric Cheminay; Ariane Volkmann; Trevor Brasel; Ricardo Carrion; Luis D Giavedoni; Jean L Patterson; Chad E Mire; Thomas W Geisbert; Jay W Hooper; Mo Weijtens; Jutta Hartkoorn-Pasma; Jerome Custers; Maria Grazia Pau; Hanneke Schuitemaker; Roland Zahn
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

Review 8.  Ebola virus disease.

Authors:  Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn
Journal:  Nat Rev Dis Primers       Date:  2020-02-20       Impact factor: 52.329

9.  Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects.

Authors:  Michelle Meyer; Bronwyn M Gunn; Delphine C Malherbe; Karthik Gangavarapu; Asuka Yoshida; Colette Pietzsch; Natalia A Kuzmina; Erica Ollmann Saphire; Peter L Collins; James E Crowe; James J Zhu; Marc A Suchard; Douglas L Brining; Chad E Mire; Robert W Cross; Joan B Geisbert; Siba K Samal; Kristian G Andersen; Galit Alter; Thomas W Geisbert; Alexander Bukreyev
Journal:  Sci Transl Med       Date:  2021-07-14       Impact factor: 17.956

10.  Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.

Authors:  Jérémie Guedj; Géraldine Piorkowski; Frédéric Jacquot; Vincent Madelain; Thi Huyen Tram Nguyen; Anne Rodallec; Stephan Gunther; Caroline Carbonnelle; France Mentré; Hervé Raoul; Xavier de Lamballerie
Journal:  PLoS Med       Date:  2018-03-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.